Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.37
-0.35 (-0.90%)
At close: Aug 15, 2025, 1:12 PM

Cytokinetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
18.47M 7.53M 94.59M 70.43M
Cost of Revenue
339.41M 330.12M 240.81M 159.94M
Gross Profit
-320.93M -322.59M -146.22M -89.51M
Operating Income
-536.25M -496.2M -324.2M -186.31M
Interest Income
51.53M 27.63M 11.34M 331K
Pretax Income
-589.53M -526.24M -388.95M -215.31M
Net Income
-589.53M -526.24M -388.95M -215.31M
Selling & General & Admin
215.31M 173.61M 177.98M 96.8M
Research & Development
329.88M n/a 6.59M 159.94M
Other Expenses
-329.88M n/a -6.59M -159.94M
Operating Expenses
215.31M 173.61M 177.98M 96.8M
Interest Expense
86.51M 57.67M 51.16M 29.33M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
554.72M 503.74M 418.79M 256.74M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
111.98M 96.52M 89.83M 76.89M
Shares Outstanding (Diluted)
111.98M 96.52M 89.83M 76.89M
EPS (Basic)
-5.26 -5.45 -4.33 -2.8
EPS (Diluted)
-5.26 -5.45 -4.33 -2.8
EBITDA
-493.48M -456.68M -329.4M -176.34M
EBIT
-503.01M -468.58M -337.8M -185.98M
Depreciation & Amortization
9.53M 11.89M 8.4M 9.64M